Table 1.

Definitions used in the systematic review.

Terms	Definitions
Clinical success- Clinical Cure	Elimination of the signs & symptoms related to the initial infection for which minocycline or non-minocycline based therapies are used.
Microbiological success- Microbiological Cure	Eradication of the causative organism from the site of infection.
Adverse Events	Onset of signs, symptoms or laboratory findings related to minocycline, its combinations or non-minocycline based regimens.
Hospital-Acquired Infection	The date of the site-specific infection occurs on or after the 3rd calendar day of admission (the day of admission is calendar day 1) [29].
Antimicrobial resistance classification	MDR: non-susceptible to ≥ 1 agent of ≥ 3 classes of antibiotics, XDR: non-susceptible to ≥ 1 agent in all but ≤2 categories, and PDR: non-susceptible to all classes or agents [30].
Site of infection	Site of isolation of the MDR, XDR or PDR A. baumannii (or A. calcoaceticus-baumannii complex) strain in the context of a new onset of relevant signs, symptoms and laboratory markers attributable to infection, based on the treating clinicians’ decision.
Surgical Site Infections	Infections that occur 30 days after surgery with no implant or within 1 year if an implant is placed and the infection appears to be related to surgery

MDR: multidrug resistant, XDR: extensively drug resistant, PDR: pandrug resistant.